Every major player in your health system gets a direct line to the industry’s most-needed insights and
the support to take action. Learn more.
Our research programs are role-specific to provide the exact insights and resources
that will make your job easier. We offer research for:
Get comprehensive access to Advisory Board research and tools on every topic we cover. Explore this option.
Create an account
On September 24, 2019, Advisory Board hosted its first-ever Cross-Industry Value Summit. Why? We think “value” may be the most overused yet least agreed upon term in our health care lexicon. On the surface, most stakeholders align on an aspirational definition of value: the right treatment for the right patient in the right setting at the right time. But all too often, legacy mistrust, siloed perspectives, and competing incentives impede the advancement of common definitions or shared frameworks for truly assessing value in U.S. health care.
In an effort to break down industry barriers and encourage more honest dialogue, this invite-only event convened 40 medical and pharmacy leaders from across the health care ecosystem—payers, providers, employers as well as third party “technology assessment” organizations increasingly opining on the value of new treatments. Scroll to learn more about what attendees took away from the day—watch an event recap video, browse a photo gallery, and read about insights shared.
Attendees participated in a structured dialogue with forward-thinking leaders—allowing them to listen with an open mind, ask difficult questions, and share honest perspectives
Participants engaged directly with other stakeholders on complex questions to acknowledge biases and identify shared points of view
Attendees discussed how near-term capabilities and innovations in data, analytics, and digital tools can track and catalyze real world outcomes tracking